logo
Share SHARE
FONT-SIZE Plus   Neg

Biogen Idec: Positive Results From CONFIRM MS Trial Show Efficacy Of Oral BG-12

Biogen Idec (BIIB) said detailed positive data from CONFIRM, the second Phase 3 trial of oral BG-12, or dimethyl fumarate, in people with relapsing-remitting multiple sclerosis, or RRMS, will be presented in three platform presentations at the 64th Annual Meeting of the American Academy of Neurology in New Orleans.

In CONFIRM, BG-12 demonstrated efficacy across a variety of clinical and radiological outcome measures, as well as favorable safety and tolerability profiles. These data, along with results from BG-12's first Phase 3 study, DEFINE, were included in regulatory applications that were submitted to U.S. and EU regulatory agencies early this year.

Earlier this year, Biogen Idec announced that it had submitted a New Drug Application to the U.S. Food and Drug Administration for marketing approval of BG-12 in the United States and a Marketing Authorisation Application to the European Medicines Agency, or EMA, for review in the European Union. The EMA has validated Biogen Idec's Marketing Authorisation Application and is reviewing the BG-12 data package. Biogen Idec is awaiting formal acceptance of its NDA for review by the FDA.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Shares of Dave & Buster's Entertainment, Inc. (PLAY) offer a compelling value proposition at the current price. We believe the stock has at least 15% upside from present levels. Despite its presence in the troubled casual-dining sector, Dave & Buster's Entertainment bucks the trend by differentiating its offerings and guest experience. French energy giant Total SA announced Monday that it has agreed to acquire E&P company Maersk Oil & Gas A/S, a unit of A.P. Moller-Maersk A/S, in a $7.45 billion share and debt transaction. Under the agreed terms, the Denmark-based shipping and oil company will receive a consideration of $4.95 billion in Total shares. A.P. Moller-Maersk shares were gaining around 4 percent. Cable-cutters have now one more reason to do so as live television streaming will be available on YouTube TV in 14 more markets in the U.S.
comments powered by Disqus
Follow RTT